Trading in TruScreen shares on the NZX has halted as the cervical cancer technology company completes another capital raising.
The company is due to announce the completion of a bookbuild – after raising just over $3 million last October. That money was used to increase sales in China, Africa,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
